Company Filing History:
5 out of 486 
1 out of 851 
1 out of 64 
Years Active: 1986-2015
Title: Brent E. Korba: Innovator in Antiviral and Antifungal Compounds
Introduction
Brent E. Korba is a notable inventor based in Laurel, MD (US), recognized for his contributions to the field of medicinal chemistry. He holds a total of 7 patents, focusing on novel compounds that target viral and fungal infections. His work has significant implications for the treatment and prevention of various infectious diseases.
Latest Patents
Korba's latest patents include innovative classes of 1,2-benzisothiazolinone and isoindolinone derivatives. These compounds are disclosed as useful in treating, preventing, and ameliorating viral, yeast, and fungal infections, including Hepatitis C Virus and candidiasis. Additionally, he has developed novel classes of viral and fungal inhibitors, which are effective against infections such as West Nile Virus and Dengue Virus.
Career Highlights
Throughout his career, Brent E. Korba has worked with prestigious institutions, including Georgetown University. His research has led to significant advancements in the development of therapeutic agents aimed at combating infectious diseases.
Collaborations
Korba has collaborated with esteemed colleagues, including John L. Gerin and John L. Casey, contributing to the advancement of his research and innovations.
Conclusion
Brent E. Korba's work in developing antiviral and antifungal compounds showcases his dedication to improving public health through innovative solutions. His contributions continue to impact the field of medicinal chemistry significantly.